๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide โ—† The โ‚ฌ100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany โ—† Ireland's โ‚ฌ93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact โ—† The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery โ—† GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons โ—† Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing โ—† Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines โ—† Trumpโ€™s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications โ—† Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide โ—† The โ‚ฌ100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany โ—† Ireland's โ‚ฌ93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact โ—† The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery โ—† GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons โ—† Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing โ—† Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines โ—† Trumpโ€™s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications โ—†
Updated 04 Jul 2026 ยท HPRA open data

Lenalidomide - Medicines in Ireland

55 authorised products containing Lenalidomide, from the HPRA register.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0โ€“9
Showing 55 authorised medicines
MedicineActive substanceLicence holderStatus
Lenalidomide Accord 10 mg hard capsules
EU/1/18/1316/006-007
Lenalidomide Accord Healthcare S.L.U. โ€”
Lenalidomide Accord 15 mg hard capsules
EU/1/18/1316/008-009
Lenalidomide Accord Healthcare S.L.U. โ€”
Lenalidomide Accord 2.5 mg hard capsules
EU/1/18/1316/001-002
Lenalidomide Accord Healthcare S.L.U. โ€”
Lenalidomide Accord 20 mg hard capsules
EU/1/18/1316/010
Lenalidomide Accord Healthcare S.L.U. โ€”
Lenalidomide Accord 25 mg hard capsules
EU/1/18/1316/011
Lenalidomide Accord Healthcare S.L.U. โ€”
Lenalidomide Accord 5 mg hard capsules
EU/1/18/1316/003-004
Lenalidomide Accord Healthcare S.L.U. โ€”
Lenalidomide Accord 7.5 mg hard capsules
EU/1/18/1316/005
Lenalidomide Accord Healthcare S.L.U. โ€”
Lenalidomide Clonmel 10 mg hard capsules
PA0126/320/004
Lenalidomide Clonmel Healthcare Ltd Marketed
Lenalidomide Clonmel 15 mg hard capsules
PA0126/320/005
Lenalidomide Clonmel Healthcare Ltd Marketed
Lenalidomide Clonmel 2.5 mg hard capsules
PA0126/320/001
Lenalidomide Clonmel Healthcare Ltd Not marketed
Lenalidomide Clonmel 20 mg hard capsules
PA0126/320/006
Lenalidomide Clonmel Healthcare Ltd Marketed
Lenalidomide Clonmel 25 mg hard capsules
PA0126/320/007
Lenalidomide Clonmel Healthcare Ltd Marketed
Lenalidomide Clonmel 5 mg hard capsules
PA0126/320/002
Lenalidomide Clonmel Healthcare Ltd Marketed
Lenalidomide Clonmel 7.5 mg hard capsules
PA0126/320/003
Lenalidomide Clonmel Healthcare Ltd Not marketed
Lenalidomide Grindeks 10 mg hard capsules
PA22992/004/004
Lenalidomide AS Grindeks โ€”
Lenalidomide Grindeks 15 mg hard capsules
PA22992/004/005
Lenalidomide AS Grindeks โ€”
Lenalidomide Grindeks 2.5 mg hard capsules
PA22992/004/001
Lenalidomide AS Grindeks โ€”
Lenalidomide Grindeks 20 mg hard capsules
PA22992/004/006
Lenalidomide AS Grindeks โ€”
Lenalidomide Grindeks 25 mg hard capsules
PA22992/004/007
Lenalidomide AS Grindeks โ€”
Lenalidomide Grindeks 5 mg hard capsules
PA22992/004/002
Lenalidomide AS Grindeks โ€”
Lenalidomide Grindeks 7.5 mg hard capsules
PA22992/004/003
Lenalidomide AS Grindeks โ€”
Lenalidomide Krka 10 mg hard capsules
EU/1/20/1519/007-008
Lenalidomide hydrochloride hydrate, Lenalidomide KRKA, d.d., Novo mesto โ€”
Lenalidomide Krka 15 mg hard capsules
EU/1/20/1519/009-010
Lenalidomide hydrochloride hydrate, Lenalidomide KRKA, d.d., Novo mesto โ€”
Lenalidomide Krka 2.5 mg hard capsules
EU/1/20/1519/001-002
Lenalidomide hydrochloride hydrate, Lenalidomide KRKA, d.d., Novo mesto โ€”
Lenalidomide Krka 20 mg hard capsules
EU/1/20/1519/011-012
Lenalidomide hydrochloride hydrate, Lenalidomide KRKA, d.d., Novo mesto โ€”
Lenalidomide Krka 25 mg hard capsules
EU/1/20/1519/013-014
Lenalidomide hydrochloride hydrate, Lenalidomide KRKA, d.d., Novo mesto โ€”
Lenalidomide Krka 5 mg hard capsules
EU/1/20/1519/003-004
Lenalidomide hydrochloride hydrate, Lenalidomide KRKA, d.d., Novo mesto โ€”
Lenalidomide Krka 7.5 mg hard capsules
EU/1/20/1519/005-006
Lenalidomide hydrochloride hydrate, Lenalidomide KRKA, d.d., Novo mesto โ€”
Lenalidomide Mylan 10 mg hard capsules
EU/1/20/1490/009-010
Lenalidomide Mylan Pharmaceuticals Limited โ€”
Lenalidomide Mylan 15 mg hard capsules
EU/1/20/1490/011-012
Lenalidomide Mylan Pharmaceuticals Limited โ€”
Lenalidomide Mylan 2.5 mg hard capsules
EU/1/20/1490/001-003
Lenalidomide Mylan Pharmaceuticals Limited โ€”
Lenalidomide Mylan 20 mg hard capsules
EU/120/1490/013-015
Lenalidomide Mylan IRE Healthcare Limited โ€”
Lenalidomide Mylan 25 mg hard capsules
EU/1/20/1490/016-018
Lenalidomide Mylan Pharmaceuticals Limited โ€”
Lenalidomide Mylan 5 mg hard capsules
EU/1/20/1490/004-005
Lenalidomide Mylan Pharmaceuticals Limited โ€”
Lenalidomide Mylan 7.5 mg hard capsules
EU/1/20/1490/006-008
Lenalidomide Mylan Pharmaceuticals Limited โ€”
Lenalidomide Rowex 10 mg hard capsules
PA0711/302/004
Lenalidomide Rowex Limited, Marketed
Lenalidomide Rowex 15 mg hard capsules
PA0711/302/005
Lenalidomide Rowex Limited, Marketed
Lenalidomide Rowex 2.5 mg hard capsules
PA0711/302/001
Lenalidomide Rowex Limited, Not marketed
Lenalidomide Rowex 20 mg hard capsules
PA0711/302/006
Lenalidomide Rowex Limited, Not marketed
Lenalidomide Rowex 25 mg hard capsules
PA0711/302/007
Lenalidomide Rowex Limited, Marketed
Lenalidomide Rowex 5 mg hard capsules
PA0711/302/002
Lenalidomide Rowex Limited, Marketed
Lenalidomide Rowex 7.5 mg hard capsules
PA0711/302/003
Lenalidomide Rowex Limited, Not marketed
Lenalidomide Teva 10 mg hard capsules
PA1986/051/004
Lenalidomide Teva B.V. Marketed
Lenalidomide Teva 15 mg hard capsules
PA1986/051/005
Lenalidomide Teva B.V. Marketed
Lenalidomide Teva 20 mg hard capsules
PA1986/051/006
Lenalidomide Teva B.V. Marketed
Lenalidomide Teva 25 mg hard capsules
PA1986/051/007
Lenalidomide Teva B.V. Marketed
Lenalidomide Teva 5 mg hard capsules
PA1986/051/002
Lenalidomide Teva B.V. Marketed
Lenalidomide Teva 7.5 mg hard capsules
PA1986/051/003
Lenalidomide Teva B.V. Not marketed
Revlimid 10 mg hard capsules
EU/1/07/391/002
Lenalidomide Bristol-Myers Squibb Pharma EEIG โ€”
Revlimid 15 mg hard capsules
EU/1/07/391/003
Lenalidomide Bristol-Myers Squibb Pharma EEIG โ€”
1 2 โ†’
Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 12 August 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (โ€œAuthorised or Transfer Pending Productsโ€), licensed CC BY 4.0, refreshed daily. Regulatory information only โ€” not medical advice.